PT-141 is bremelanotide, an FDA-approved prescription medicine (brand name Vyleesi). It is approved only for hypoactive sexual desire disorder (HSDD) in premenopausal women — it is not approved for men and not approved as a general libido product, and other uses discussed online are not approved uses. The approved product is a prefilled autoinjector, not a vial: research vials are not the approved product. This calculator is an educational maths tool, not medical advice. It turns your vial strength, BAC water volume and target dose into a precise draw on a U-100 insulin syringe, so you can check the maths yourself and talk through any dose with your clinician or pharmacy. All dosing information on this page is reference information only, framed as educational information from the FDA-approved Vyleesi label and commonly discussed reference ranges.
The worked example used throughout this page is a 10 mg vial mixed with 2 mL of bacteriostatic water. That gives a concentration of 5 mg/mL — 5,000 mcg/mL, 50 mcg per unit on a U-100 syringe — so a 1 mg dose is 0.2 mL, which is 20 units, the 1.75 mg Vyleesi label dose is 0.35 mL (35 units), and a 2 mg dose is 0.4 mL (40 units). One vial gives ten 1 mg doses, or five 2 mg doses. A 1 mL syringe holds 100 units, so those 20 units sit at the 20-unit mark on the barrel. The same maths works for any vial strength, from 5 mg to 20 mg: divide the vial strength by the water volume to get the concentration, then divide your target dose by the concentration to get the volume to draw.
PT-141 (bremelanotide) is a melanocortin receptor agonist that acts on the MC4R receptor. It was developed from Melanotan II research. Its approved use is narrow — HSDD in premenopausal women — and the Vyleesi label sets strict limits: no more than one dose in 24 hours and no more than 8 doses per month.
PT-141 Reconstitution Calculator
Enter your vial size, bacteriostatic water, and target dose to get an exact syringe draw – with a live visual and a round-unit optimizer so you never eyeball an odd tick mark again.
Same three formulas as the homepage calculator: concentration = vial strength divided by BAC water; draw volume = dose divided by concentration; units = draw volume × 100 on a U-100 syringe.
Quick Answers: PT-141 Doses in Units
These are the quick answers for the most common example on this page — a 10 mg vial of PT-141 mixed with 2 mL of BAC water, which gives a concentration of 5 mg/mL (5,000 mcg/mL, 50 mcg per unit). Read them off a U-100 insulin syringe, where a 1 mL syringe holds 100 units. This is educational maths, not a dose recommendation; the doses below are the Vyleesi label dose (1.75 mg) and common reference doses, and you should follow the label and your clinician or pharmacy instructions.
| Target dose | Draw volume | Units (U-100) |
|---|---|---|
| 0.5 mg | 0.1 mL | 10 units |
| 1 mg | 0.2 mL | 20 units |
| 1.75 mg | 0.35 mL | 35 units |
| 2 mg | 0.4 mL | 40 units |
The 1 mg, 1.75 mg and 2 mg draws all fit in a single 1 mL syringe. A 10 mg vial gives ten 1 mg doses, five 2 mg doses, or five 1.75 mg doses with 1.25 mg left over.
Quick Math Example
Take the 10 mg vial with 2 mL of BAC water as the first example, and the 10 mg vial with 1 mL of BAC water as the second: the first gives 5 mg/mL, so 1 mg is 20 units, the 1.75 mg label dose is 35 units and 2 mg is 40 units; the second gives 10 mg/mL, so 1 mg is 10 units and 1.75 mg is 17.5 units — a half-unit draw, which is awkward on a syringe. The third example is a 5 mg vial with 2 mL of BAC water: 2.5 mg/mL, so 1 mg is 40 units and 2 mg is 80 units. The pattern is the same every time: concentration first, then the draw, then the units.
How the PT-141 Calculation / Math Works
Step 1 — Find the concentration. Divide the vial strength by the bacteriostatic water volume. A 10 mg vial with 2 mL of water is 10 ÷ 2 = 5 mg/mL — that is 5,000 mcg/mL (multiply mg by 1,000 to get mcg: 10 mg is 10,000 mcg), or 50 mcg per unit on a U-100 syringe — because each unit is 0.01 mL, so 5 mg/mL × 0.01 mL = 0.05 mg, or 50 mcg.
Step 2 — Find the draw volume. Divide the target dose by the concentration to get an exact volume. For a 1 mg dose (1,000 mcg) from a 5 mg/mL mix: 1 ÷ 5 = 0.2 mL, which is 20 units. A 10 mg vial at a 1 mg dose gives 10 doses. For the 1.75 mg Vyleesi label dose from the same mix: 1.75 ÷ 5 = 0.35 mL, or 35 units. For a 2 mg dose from the same mix: 2 ÷ 5 = 0.4 mL, or 40 units.
Step 3 — Turn the volume into units. On a U-100 insulin syringe, 1 mL is 100 units, so multiply the draw volume in mL by 100. A 0.2 mL draw is 20 units; a 0.35 mL draw is 35 units; a 0.4 mL draw is 40 units; a 1.0 mL draw is 100 units and a 2.0 mL draw is 200 units. The unit markings are in hundredths of a millilitre: 0.01 mL is 1 unit. Small draws are easier to read on a 0.5 mL (50 unit) syringe.
Dosage Formula
Three formulas do all the work. Use them in this order, and keep the units straight (mg for the dose, mL for the water and the draw, mcg only when you need to compare labels).
- Concentration (mg/mL) = vial mg ÷ BAC water mL. Example: 10 mg ÷ 2 mL = 5 mg/mL.
- Draw volume (mL) = dose mg ÷ concentration (mg/mL). Example: 1 mg ÷ 5 mg/mL = 0.2 mL.
- U-100 units = draw volume (mL) × 100. Example: 0.2 mL × 100 = 20 U-100 units.
On a U-100 insulin syringe the scale is simple: 1 mL is 100 units, so each unit is 0.01 mL. The formulas do not change with the vial size — only the numbers do. A stronger mix gives a smaller draw for the same dose, and a weaker mix gives a larger draw. The Vyleesi label dose of 1.75 mg from this mix is 0.35 mL — 35 units.
PT-141 10 mg Vial with 2 mL Example
This is the reference example for the whole page. Start with the PT-141 vial: a 10 mg vial + 2 mL of BAC water. The Vyleesi label dose is 1.75 mg as needed, so work the 1 mg, 1.75 mg and 2 mg draws from the same mix.
- Concentration: 10 ÷ 2 = 5 mg/mL (5,000 mcg/mL). Written out: 10 mg / 2 mL = 5 mg/mL.
- Draw volume: the target dose is 1 mg (1,000 mcg), so 1 ÷ 5 = 0.2 mL; for 1.75 mg it is 1.75 ÷ 5 = 0.35 mL; for 2 mg it is 2 ÷ 5 = 0.4 mL.
- Units: 0.2 × 100 = 20 U-100 units for 1 mg; 0.35 × 100 = 35 U-100 units for 1.75 mg; 0.4 × 100 = 40 U-100 units for 2 mg. Draw 20 units for 1 mg, 35 units for the 1.75 mg label dose, or 40 units for 2 mg.
So: 10 mg in 2 mL gives 5 mg/mL, and 1 mg from that mix is 0.2 mL — 20 units. One vial gives ten 1 mg doses, five 2 mg doses, or five 1.75 mg doses with 1.25 mg left over.
10 mg Vial + 1 mL BAC Water, 1 mg Dose
Take a 1 mg dose from the same vial with less water: a 10 mg PT-141 vial with 1 mL of BAC water. This is the most concentrated mix on this page, so the draws are small and the 1.75 mg label dose lands on a half-unit marking.
- Concentration: 10 mg / 1 mL = 10 mg/mL (10,000 mcg/mL).
- Draw volume: 1,000 mcg / 10,000 mcg per mL = 0.1 mL.
- Units: 0.1 mL × 100 = 10 U-100 units.
The 1.75 mg label dose from this mix is 1.75 ÷ 10 = 0.175 mL — 17.5 units — a half-unit draw that is awkward on a syringe, so a more dilute mix makes small doses easier to measure. A 2 mg dose is 2 ÷ 10 = 0.2 mL — 20 units.
5 mg Vial + 2 mL BAC Water, 1 mg Dose
Now take a 1 mg dose from a smaller vial: a 5 mg PT-141 vial in 2 mL of BAC water. This is the most dilute mix on this page, so the draws are larger and easier to read on the syringe.
- Concentration: 5 ÷ 2 = 2.5 mg/mL (2,500 mcg/mL).
- Draw volume: 1 ÷ 2.5 = 0.4 mL.
- Units: 0.4 × 100 = 40 units on a U-100 syringe.
From this mix, the 1.75 mg label dose is 1.75 ÷ 2.5 = 0.7 mL — 70 units, and 2 mg is 0.8 mL — 80 units. A 5 mg vial gives five 1 mg doses, or two 2 mg doses with 1 mg left over.
Example PT-141 Dosage Table
Always verify your vial label before you draw — this table is for education, and the same dose can be a very different number of units depending on the mix. Check the table against the calculator above before you rely on it.
| Vial | BAC water | Concentration | Dose | Draw | Units (U-100) |
|---|---|---|---|---|---|
| 10 mg | 2 mL | 5 mg/mL | 1 mg | 0.2 mL | 20 units |
| 10 mg | 2 mL | 5 mg/mL | 1.75 mg | 0.35 mL | 35 units |
| 10 mg | 2 mL | 5 mg/mL | 2 mg | 0.4 mL | 40 units |
| 10 mg | 1 mL | 10 mg/mL | 1 mg | 0.1 mL | 10 units |
| 10 mg | 1 mL | 10 mg/mL | 1.75 mg | 0.175 mL | 17.5 units |
| 5 mg | 2 mL | 2.5 mg/mL | 1 mg | 0.4 mL | 40 units |
| 5 mg | 2 mL | 2.5 mg/mL | 2 mg | 0.8 mL | 80 units |
Worked from the concentration each time: dose ÷ concentration = draw; draw × 100 = U-100 units. Check your own vial against the calculator above before you rely on it.
Choosing BAC Water for a PT-141 Vial
There is no single right amount of BAC water: the reconstitution volume sets the strength of the mix, and the right choice depends on the size of the vial and how large the draws are. A lower concentration gives clearer, more readable unit marks for small doses — but every time the dose changes, re-run the maths for the new dose.
| BAC water (10 mg vial) | Concentration | Draw for a 1 mg dose | Units per dose |
|---|---|---|---|
| 1 mL | 10 mg/mL | 0.1 mL | 10 units |
| 2 mL | 5 mg/mL | 0.2 mL | 20 units |
| 3 mL | 3.33 mg/mL | 0.3 mL | 30 units |
2 mL is the practical middle ground for a 10 mg vial: from this mix the reference doses are easy to read — 1 mg is 0.2 mL (20 units), the 1.75 mg label dose is 0.35 mL (35 units) and 2 mg is 0.4 mL (40 units). Less water gives smaller, harder-to-read draws; with 1 mL of water the 1.75 mg dose is 17.5 units — a half-unit draw — so a more dilute mix makes small doses easier to measure.
PT-141 Dosage Calculator in Units — Dose to U-100 Units Chart
The chart below uses the default water volume on this page: 2 mL of BAC water in a 10 mg vial of PT-141 (5 mg/mL). Each unit is 50 mcg of PT-141 at this concentration.
| Dose | Draw volume | Units (U-100) |
|---|---|---|
| 0.5 mg | 0.1 mL | 10 units |
| 1 mg | 0.2 mL | 20 units |
| 1.75 mg | 0.35 mL | 35 units |
| 2 mg | 0.4 mL | 40 units |
All the draws in this chart fit in a single 1 mL U-100 insulin syringe (100 units = 1 mL). For a different vial or water volume, the draws change — re-run the maths for your own mix.
PT-141 Reconstitution Reference — Units per Dose by Vial Size (2 mL BAC Water)
Use 2 mL BAC water throughout this reference. It is reference maths, not a dose recommendation — follow the label and your clinician or pharmacy instructions.
| Vial | Concentration | 1 mg | 1.75 mg | 2 mg |
|---|---|---|---|---|
| 5 mg | 2.5 mg/mL | 0.4 mL / 40 u | 0.7 mL / 70 u | 0.8 mL / 80 u |
| 10 mg | 5 mg/mL | 0.2 mL / 20 u | 0.35 mL / 35 u | 0.4 mL / 40 u |
| 20 mg | 10 mg/mL | 0.1 mL / 10 u | 0.175 mL / 17.5 u | 0.2 mL / 20 u |
Draws over 1 mL do not fit a standard 1 mL U-100 insulin syringe. The 20 mg vial gives the most concentrated mix at 2 mL of water, so its 1.75 mg draw is 17.5 units — a half-unit draw; a more dilute mix is easier to measure.
Syringe
Always check the syringe label before you draw. A U-100 insulin syringe is the standard scale: 1 mL is 100 units, so each unit is 0.01 mL. From the standard mix on this page — a 10 mg vial in 2 mL of BAC water (5 mg/mL) — a 1 mg dose is 0.2 mL, or 20 units, and a 2 mg dose is 0.4 mL, or 40 units. Draws above 100 units do not fit a single 1 mL syringe — several of the more dilute vial-table rows exceed it, so check your own draw first. A 0.5 mL (50-unit) syringe is useful for the smallest draws, and a 29–31 gauge needle is typical for this injection. A U-40 syringe gives a different scale — use U-100 only.
PT-141 Reconstitution by Vial Size
PT-141 is bremelanotide, an FDA-approved prescription medicine (Vyleesi), approved only for hypoactive sexual desire disorder (HSDD) in premenopausal women. The doses below are label and common reference doses for education — the Vyleesi label dose is 1.75 mg as needed, at least 45 minutes before anticipated sexual activity, with a maximum of 1 dose per 24 hours and 8 doses per month. The tables give the dose in millilitres and U-100 units for each vial size, with 1 mL, 2 mL and 3 mL BAC water. Keep the water at or below 3 mL for a standard vial, and always follow the label and your prescriber’s instructions.
5 mg Vial
A 5 mg vial gives five 1 mg doses, or two 2 mg doses with 1 mg left over. At 2.5 mg/mL (2 mL of water), a 1 mg dose is 40 units and the 1.75 mg label dose is 70 units.
| Water | Concentration | 1 mg | 1.75 mg | 2 mg |
|---|---|---|---|---|
| 1 mL | 5 mg/mL | 0.2 mL (20 u) | 0.35 mL (35 u) | 0.4 mL (40 u) |
| 2 mL | 2.5 mg/mL | 0.4 mL (40 u) | 0.7 mL (70 u) | 0.8 mL (80 u) |
| 3 mL | 1.67 mg/mL | 0.6 mL (60 u) | 1.05 mL (105 u) | 1.2 mL (120 u) |
10 mg Vial
The 10 mg vial is the reference example on this page. At 5 mg/mL (2 mL of water), a 1 mg dose is 20 units, the 1.75 mg label dose is 35 units, and a 2 mg dose is 40 units. With 1 mL of water the 1.75 mg label dose is 17.5 units — a half-unit draw — so a more dilute mix is easier to measure.
| Water | Concentration | 1 mg | 1.75 mg | 2 mg |
|---|---|---|---|---|
| 1 mL | 10 mg/mL | 0.1 mL (10 u) | 0.175 mL (17.5 u) | 0.2 mL (20 u) |
| 2 mL | 5 mg/mL | 0.2 mL (20 u) | 0.35 mL (35 u) | 0.4 mL (40 u) |
| 3 mL | 3.33 mg/mL | 0.3 mL (30 u) | 0.525 mL (52.5 u) | 0.6 mL (60 u) |
20 mg Vial
A 20 mg vial gives twenty 1 mg doses, or ten 2 mg doses. At 10 mg/mL (2 mL of water), a 1 mg dose is 10 units and the 1.75 mg label dose is 17.5 units — a half-unit draw — so a more dilute mix is easier to measure.
| Water | Concentration | 1 mg | 1.75 mg | 2 mg |
|---|---|---|---|---|
| 1 mL | 20 mg/mL | 0.05 mL (5 u) | 0.0875 mL (8.75 u) | 0.1 mL (10 u) |
| 2 mL | 10 mg/mL | 0.1 mL (10 u) | 0.175 mL (17.5 u) | 0.2 mL (20 u) |
| 3 mL | 6.67 mg/mL | 0.15 mL (15 u) | 0.2625 mL (26.25 u) | 0.3 mL (30 u) |
Reconstitution
Reconstitution is simple, but the order matters. Work with clean hands and clean equipment.
- Wash your hands. Wipe both vial stoppers with an alcohol swab and let the alcohol dry before you pierce the stoppers.
- Draw the BAC water volume into a syringe — draw up bacteriostatic water, not plain sterile water — and add it slowly down the inner wall of the vial of lyophilised powder. For example, 2 mL into a 10 mg vial gives 5 mg/mL; 2 mL into a 5 mg vial gives 2.5 mg/mL.
- Swirl gently until the powder has dissolved into a clear solution. Do not shake the vial.
- Draw the dose with a 100-unit insulin syringe (1 mL U-100). From the 5 mg/mL mix (10 mg vial in 2 mL of water), 1 mg is 20 units, the 1.75 mg label dose is 35 units and 2 mg is 40 units.
- Choose an injection site — abdomen, outer thigh, or upper arm — pinch a skin fold, insert the needle at a 45 to 90 degree angle, inject slowly, and hold for 5 seconds before withdrawing. Use a 29 to 31 gauge needle and a new sterile syringe for every injection.
Storage
Store reconstituted PT-141 in a refrigerator at 2–8 °C (36–46 °F). Do not freeze it: freezing can damage the peptide, and a vial that has frozen should be discarded — never try to thaw and re-use it. Keep the vial upright in its box or another dark place so it is protected from light, and keep it out of reach of children and pets. Once mixed, use the vial within about 4 weeks. Write the mixing date and the discard date on the label so you can check at a glance — for example, a vial mixed on the 1st of the month should be finished by about the 29th. Do not leave a mixed vial at room temperature for long periods, and do not store it in the freezer or in a car. If it looks cloudy or contains particles, do not use it. This is educational information only, not medical advice; when in doubt, ask a pharmacist.
Dosing Schedule
PT-141 is bremelanotide, an FDA-approved prescription medicine (Vyleesi), approved only for hypoactive sexual desire disorder (HSDD) in premenopausal women. The doses and limits below are label reference information for education. Your prescriber decides the dose and timing; this page shows the reference doses so you can see how the maths changes with the dose. The Vyleesi label dose is as needed, not daily: at least 45 minutes before anticipated sexual activity, with a maximum of 1 dose per 24 hours and 8 doses per month. Effects typically begin around 45–60 minutes (reference information).
| Reference | Dose | When |
|---|---|---|
| Label dose (Vyleesi) | 1.75 mg as needed | At least 45 minutes before anticipated sexual activity, by subcutaneous injection |
| Label limit — per day | Max 1 dose per 24 hours | No more than one dose in 24 hours |
| Label limit — per month | Max 8 doses per month | No more than 8 doses in a month |
| Common research / reference range | 0.5–2 mg as needed | As needed (non-approved reference information; discussed in research references) |
The dose is as needed, not daily, and the label limits are strict: no more than 1 dose in 24 hours and no more than 8 doses in a month. Do not change a prescribed dose or timing without your prescriber’s instruction, and always follow the label and your prescriber’s instructions.
What You Need
To reconstitute a vial of PT-141 you need the following:
- A vial of lyophilised PT-141 (bremelanotide) powder.
- Bacteriostatic water (BAC water) — 0.9% benzyl alcohol in sterile water.
- A 1 mL U-100 insulin syringe (100 units).
- Alcohol swabs.
- A sharps container.
A sterile mixing syringe and needle are also useful for drawing up the BAC water. Never use tap water, and never reuse a needle or syringe — use a new sterile syringe for every draw and put used sharps straight into a sharps container. The approved Vyleesi product is a prefilled autoinjector, not a vial — research vials are not the approved product. This is educational only.
Comparing Options
PT-141 (bremelanotide, brand name Vyleesi) and flibanserin (brand name Addyi) are both approved only for hypoactive sexual desire disorder (HSDD) in premenopausal women, but they work very differently. The comparison below is informational only.
| Option | How it works | Dosing | Approval scope |
|---|---|---|---|
| PT-141 (bremelanotide / Vyleesi) | Melanocortin receptor agonist (MC4R) — acts on melanocortin receptors in the brain | As needed by subcutaneous injection (prefilled autoinjector), at least 45 minutes before anticipated sexual activity | FDA-approved only for HSDD in premenopausal women |
| Flibanserin (Addyi) | Acts on brain neurotransmitters (serotonin and dopamine pathways) — a different mechanism from PT-141 | Daily oral tablet | FDA-approved only for HSDD in premenopausal women |
The two options differ in mechanism and in dosing: PT-141 is an as-needed injection and flibanserin is a daily pill. Both are approved only for HSDD in premenopausal women, and neither is approved for men or as a general libido product. Talk to your prescriber about which option, if any, is appropriate for you.
What Is PT-141?
PT-141 is bremelanotide, a melanocortin receptor agonist that acts on the MC4R receptor in the brain. It was developed from Melanotan II research. It is sold as the prescription medicine Vyleesi, a prefilled autoinjector.
PT-141 (bremelanotide) is FDA-approved only for hypoactive sexual desire disorder (HSDD) in premenopausal women — it is not approved for men and not approved as a general libido product, and other uses discussed online are not approved uses. The approved product is the Vyleesi prefilled autoinjector, not a vial: research vials sold online are not the approved product.
Sources/References
The dose figures and product information on this page are drawn from the following sources:
- Vyleesi (bremelanotide) Prescribing Information, AMAG Pharmaceuticals — FDA-approved label. Label dose 1.75 mg as needed, at least 45 minutes before anticipated sexual activity; maximum 1 dose per 24 hours and 8 doses per month. Approved only for hypoactive sexual desire disorder (HSDD) in premenopausal women.
- FDA approval information for Vyleesi (bremelanotide) — FDA-approved prescription medicine for HSDD in premenopausal women.
- Common reference information for PT-141 research use — reference dose range 0.5–2 mg as needed (non-approved reference information; discussed in research references).
All calculations on this page were worked from the standard formula — concentration = vial strength divided by BAC water; draw volume = dose divided by concentration; units = draw volume × 100 on a U-100 syringe — and checked against the calculator above.
FAQ
How many units is 1 mg of PT-141? For the standard mix on this page — a 10 mg vial in 2 mL of BAC water (5 mg/mL) — 1 mg is 0.2 mL, which is 20 units on a U-100 syringe. Each unit is 50 mcg of PT-141 at that concentration.
How many units is 1.75 mg of PT-141? From the same standard mix (10 mg in 2 mL of BAC water, 5 mg/mL), 1.75 mg is 0.35 mL, which is 35 units on a U-100 syringe. This is the Vyleesi label dose.
How many units is 2 mg of PT-141? From the same standard mix (10 mg in 2 mL of BAC water, 5 mg/mL), 2 mg is 0.4 mL, which is 40 units on a U-100 syringe.
How much BAC water do I add to a 10 mg PT-141 vial? There is no single amount: 2 mL is the standard example on this page, and the “Reconstitution by Vial Size” section shows 1 mL, 2 mL and 3 mL. With 2 mL, a 10 mg vial gives 5 mg/mL, so 1 mg is 20 units, 1.75 mg is 35 units and 2 mg is 40 units. With 1 mL of water the 1.75 mg dose is 17.5 units — a half-unit draw.
Which syringe do I use? A 1 mL U-100 insulin syringe (100 units), usually 29–31 gauge. Always check the syringe label — a U-100 syringe has 100 units per 1 mL. A U-40 syringe reads differently, so do not use one for a U-100 dose.
How long before it works? The Vyleesi label says to take it at least 45 minutes before anticipated sexual activity. Effects typically begin around 45–60 minutes (reference information).
Is PT-141 FDA approved? Yes. PT-141 (bremelanotide) is FDA-approved as Vyleesi, a prescription medicine, approved only for hypoactive sexual desire disorder (HSDD) in premenopausal women. It is not approved for men and not approved as a general libido product, and other uses discussed online are not approved uses. The approved product is the Vyleesi prefilled autoinjector, not a vial.
How do I store PT-141? Refrigerate reconstituted PT-141 at 2–8 °C (36–46 °F), do not freeze it, protect it from light, and use it within about 4 weeks of mixing.